Cargando…
Dasatinib-Loaded Erythrocytes Trigger Apoptosis in Untreated Chronic Myelogenous Leukemic Cells: A Cellular Reservoir Participating in Dasatinib Efficiency
Dasatinib is an ABL1 tyrosine kinase inhibitor (TKI) with a short in vivo plasmatic half-life but with good efficiency, which is not fully understood. We investigated the possibility that circulating erythrocytes store and then provide dasatinib to target cells. In vitro coincubation of dasatinib-tr...
Autores principales: | Airiau, Kelly, Turcq, Béatrice, Bouchet, Stéphane, Laharanne, Elodie, Vial, Jean-Philippe, Etienne, Gabriel, Mahon, François-Xavier, Belloc, Francis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6745996/ https://www.ncbi.nlm.nih.gov/pubmed/31723769 http://dx.doi.org/10.1097/HS9.0000000000000041 |
Ejemplares similares
-
A Dasatinib-Induced Chylothorax Persisting After the Discontinuation of Dasatinib
por: Bradt, Nicolas, et al.
Publicado: (2022) -
Dasatinib induces severe hemorrhagic colitis in a patient with accelerated phase of chronic myelogenous leukemia
por: Yim, Eunjung, et al.
Publicado: (2018) -
Dasatinib-induced nephrotic syndrome in a patient with chronic myelogenous leukemia: a case report
por: Ochiai, Shoko, et al.
Publicado: (2019) -
Dasatinib-induced Reversible Demyelinating Peripheral Neuropathy and Successful Conversion to Nilotinib in Chronic Myelogenous Leukemia
por: Inoue, Hiroyasu, et al.
Publicado: (2020) -
A Single Nucleotide Polymorphism in cBIM Is Associated with a Slower Achievement of Major Molecular Response in Chronic Myeloid Leukaemia Treated with Imatinib
por: Augis, Vanessa, et al.
Publicado: (2013)